Compare BDTX & GLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BDTX | GLND |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 98.4M |
| IPO Year | 2020 | N/A |
| Metric | BDTX | GLND |
|---|---|---|
| Price | $2.60 | $2.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | 802.4K | ★ 1.6M |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $2.92 |
| 52 Week High | $4.94 | $12.80 |
| Indicator | BDTX | GLND |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 26.73 |
| Support Level | $2.45 | N/A |
| Resistance Level | $2.79 | $8.53 |
| Average True Range (ATR) | 0.20 | 1.07 |
| MACD | -0.06 | -0.25 |
| Stochastic Oscillator | 7.26 | 0.69 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.